Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Heat Biologics Appoints Head of R&D | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Heat Biologics Appoints Head of R&D

Schreiber brings expertise the field of tumor immunology

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Taylor H. Schreiber, M.D., Ph.D., has been appointed vice president of R&D at Heat Biologics, Inc. to lead the company’s ImPACT Therapy preclinical drug development research team.
 
Dr. Schreiber brings expertise the field of tumor immunology and is co-inventor of significant elements of Heat’s ImPACT Technology platform. He has more than 10 years of lab experience and skills in the discovery of therapeutic immuno-oncology compounds. Dr. Schreiber is also a co-inventor of TNFRSF25 agonist technology and has authored numerous tumor immunology and heat shock protein-based cancer immunotherapy abstracts and publications.
 
Jeff Wolf, chief executive officer of Heat, said, “Dr. Schreiber has been intimately involved in the progression of gp96 heat shock protein immunotherapy both as a Ph.D. researcher and as a post-doctoral fellow in the laboratory of Eckhard Podack, M.D., Ph.D., the inventor of Heat’s ImPACT Technology platform. Under Taylor’s leadership, the Company will seek to generate and evaluate its proprietary ImPACT Therapy for new potential immunotherapeutic oncology product opportunities including the potential for use in combination with checkpoint inhibitors and T-cell costimulatory compounds.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics